1. Non-coding RNAs as therapeutic targets in cancer and its clinical application
   Xuejiao Leng et al, 2024, Journal of Pharmaceutical Analysis CrossRef
2. miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis
   Li-Ya Ji et al, 2021, Oncology Reports CrossRef
3. MicroRNAs and target molecules in bladder cancer
   Payam Kheirmand Parizi et al, 2020, Medical Oncology CrossRef
4. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis
   Chunyu Zhang et al, 2021, Frontiers in Oncology CrossRef
5. MicroRNAs: Key Players in Bladder Cancer
   Qi Li et al, 2019, Molecular Diagnosis & Therapy CrossRef
6. Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome
   Martina Tassinari et al, 2021, Nucleic Acids Research CrossRef
7. G-Quadruplexes influence pri-microRNA processing
   Samuel G. Rouleau et al, 2018, RNA Biology CrossRef
8. LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2
   Hua Zhong et al, 2018, Cancer Biomarkers CrossRef
9. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer
   Guicheng Zou et al, 2019, Cancer Biomarkers CrossRef
10. The Role of MicroRNA in the Metastatic Phenotype of Bladder Cancer
    Aaron Perecman et al, 2022, Urologic Cancers CrossRef
11. Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
    Sara Monteiro-Reis et al, 2019, International Journal of Molecular Sciences CrossRef
12. MicroRNA as a Biomarker for Diagnostic, Prognostic, and Therapeutic Purpose in Urinary Tract Cancer
    Amro M. Soliman et al, 2021, Processes CrossRef